BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 20864322)

  • 21. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of corticosteroids for fetal maturation on perinatal outcomes.
    NIH Consens Statement; 1994 Feb 28-Mar 2; 12(2):1-24. PubMed ID: 7728157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ; Anbar RD; Mettelman BB
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
    Lodygensky GA; Rademaker K; Zimine S; Gex-Fabry M; Lieftink AF; Lazeyras F; Groenendaal F; de Vries LS; Huppi PS
    Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].
    Groneck P; Speer CP
    Z Geburtshilfe Neonatol; 2005 Aug; 209(4):119-27. PubMed ID: 16138269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(2):111-7. PubMed ID: 20150750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on Postnatal Steroids.
    Halliday HL
    Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antenatal corticosteroids for fetal maturation in preterm infants.
    Anyaegbunam WI; Adetona AB
    Am Fam Physician; 1997 Sep; 56(4):1093-6. PubMed ID: 9310061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease.
    Doyle LW; Halliday HL; Ehrenkranz RA; Davis PG; Sinclair JC
    Pediatrics; 2005 Mar; 115(3):655-61. PubMed ID: 15741368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postnatal corticosteroid response in neonates < 32 weeks and relation with placental pathology.
    Koenders VM; Appels A; van Straaten HLM; Dutman AC; Hemels MAC
    Eur J Pediatr; 2023 Jan; 182(1):265-274. PubMed ID: 36318297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of inhaled corticosteroids in chronically ventilated preterm infants.
    Nelin LD; Logan JW
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):296-301. PubMed ID: 28768578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Filippone M; Nardo D; Bonadies L; Salvadori S; Baraldi E
    Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm.
    Eriksson L; Haglund B; Ewald U; Odlind V; Kieler H
    Acta Obstet Gynecol Scand; 2009; 88(8):933-8. PubMed ID: 19568962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Repeat doses of prenatal corticosteroids for women at risk of preterm birth: a difficult consensus].
    Guilherme R; Renaud C; Dommergues M; Mitanchez D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):459-68. PubMed ID: 19473782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.